U.S. Markets open in 2 hrs 18 mins
  • S&P Futures

    3,842.25
    +8.00 (+0.21%)
     
  • Dow Futures

    30,865.00
    -44.00 (-0.14%)
     
  • Nasdaq Futures

    13,474.75
    +113.25 (+0.85%)
     
  • Russell 2000 Futures

    2,154.50
    -9.50 (-0.44%)
     
  • Crude Oil

    52.32
    +0.05 (+0.10%)
     
  • Gold

    1,861.60
    +5.40 (+0.29%)
     
  • Silver

    25.68
    +0.12 (+0.49%)
     
  • EUR/USD

    1.2162
    -0.0012 (-0.0973%)
     
  • 10-Yr Bond

    1.0910
    0.0000 (0.00%)
     
  • Vix

    22.66
    +1.34 (+6.29%)
     
  • GBP/USD

    1.3679
    -0.0006 (-0.0410%)
     
  • USD/JPY

    103.8220
    +0.0610 (+0.0588%)
     
  • BTC-USD

    33,182.24
    -265.01 (-0.79%)
     
  • CMC Crypto 200

    673.40
    -3.50 (-0.52%)
     
  • FTSE 100

    6,650.31
    -44.76 (-0.67%)
     
  • Nikkei 225

    28,822.29
    +190.84 (+0.67%)
     

Medpace Holdings Inc (MEDP) President & CEO August J. Troendle Sold $4.7 million of Shares

GuruFocus.com
·2 min read

- By insider

President & CEO of Medpace Holdings Inc (30-Year Financial, Insider Trades) August J. Troendle (insider trades) sold 33,260 shares of MEDP on 12/22/2020 at an average price of $140.01 a share. The total sale was $4.7 million.


Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings Inc has a market cap of $4.98 billion; its shares were traded at around $139.350000 with a P/E ratio of 42.63 and P/S ratio of 5.88.

CEO Recent Trades:

  • President & CEO, 10% Owner August J. Troendle sold 33,260 shares of MEDP stock on 12/22/2020 at the average price of $140.01. The price of the stock has decreased by 0.47% since.

  • President & CEO, 10% Owner August J. Troendle sold 216,048 shares of MEDP stock on 12/18/2020 at the average price of $141.85. The price of the stock has decreased by 1.76% since.

  • President & CEO, 10% Owner August J. Troendle sold 14,000 shares of MEDP stock on 12/01/2020 at the average price of $130.86. The price of the stock has increased by 6.49% since.

CFO Recent Trades:

  • CFO & COO, Lab Operations Jesse J Geiger sold 4,200 shares of MEDP stock on 12/14/2020 at the average price of $142. The price of the stock has decreased by 1.87% since.

Directors and Officers Recent Trades:

  • 10% Owner Investors, Llc Medpace sold 33,260 shares of MEDP stock on 12/22/2020 at the average price of $140.01. The price of the stock has decreased by 0.47% since.

  • 10% Owner Investors, Llc Medpace sold 216,048 shares of MEDP stock on 12/18/2020 at the average price of $141.85. The price of the stock has decreased by 1.76% since.

  • General Counsel & Corp. Secy. Stephen P Ewald sold 10,000 shares of MEDP stock on 12/10/2020 at the average price of $140.07. The price of the stock has decreased by 0.51% since.

  • 10% Owner Investors, Llc Medpace sold 14,000 shares of MEDP stock on 12/01/2020 at the average price of $130.86. The price of the stock has increased by 6.49% since.

For the complete insider trading history of MEDP, click here

.This article first appeared on GuruFocus.